Search Within

Paola Ghione

Formats
  1. Meeting Abstract (58)
  2. Journal Article (26)
  3. Editorial (3)
  4. Research Letter (3)
  5. Review (2)
Groups
  1. Sloan Kettering Institute Postdocs (92)
  2. Department of Medicine (78)
  3. Hematologic Malignancies, Division of (78)
  4. Center for Hematologic Malignancies (76)
  5. Lymphoma (75)
  6. Population Sciences Research Program (59)

More Groups

People
  1. Steven Horwitz (59)
  2. Alison Moskowitz (50)
  3. Maria Palomba (45)
  4. Ahmet Dogan (37)
  5. Ariela Noy (37)
  6. Andrew Zelenetz (35)

More People

Years
  1. 2025 (9)
  2. 2024 (29)
  3. 2023 (23)
  4. 2022 (2)
  5. 2021 (6)
  6. 2020 (14)

More Years

Publications
  1. Blood (45)
  2. Hematological Oncology (8)
  3. Journal of Clinical Oncology (6)
  4. Haematologica (5)
  5. Blood Advances (4)
  6. Leukemia and Lymphoma (3)

More Publications

Publishers
  1. American Society of Hematology (49)
  2. Wiley Blackwell (12)
  3. American Society of Clinical Oncology (6)
  4. Ferrata Storti Foundation (5)
  5. Taylor & Francis Group (4)
  6. Elsevier Inc. (3)

More Publishers

Results (92)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Rituximab plus /- ibrutinib as first line therapy for marginal zone lymphoma
    Meeting Abstract

    Noy, A.; Thet, W. S.; Vemuri, S.; Seshan, V.; Batlevi, C. L.; Epstein-Peterson, Z. D.; Falchi, L.; Ghione, P.; Habermann, T. M.; Hamlin, P. A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Sequential R-CHOP/(R)-ICE and dose-adjusted EPOCH-R are both appropriate frontline treatments for newly diagnosed primary mediastinal B-cell lymphoma: Results of a retrospective analysis
    Meeting Abstract

    Bantilan, K. S.; Luttwak, E.; Moskowitz, C. H.; Matasar, M.; Straus, D. J.; Portlock, C. S.; Moskowitz, A.; Noy, A.; Palomba, M. L.; Horwitz, S.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Angioimmunoblastic versus non-angioimmunoblastic nodal T-follicular helper cell lymphomas: Single center retrospective analysis on 208 cases
    Meeting Abstract

    Sordi, B.; Eren, O. C.; Ganesan, N.; Iyengar, V.; Stuver, R.; Johnson, W. T.; Moskowitz, A.; Ghione, P.; Galasso, N.; Casper, E.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • A prospective geriatric assessment (GA) study predicting toxicities in older adults (OA) with non-Hodgkin Lymphoma (NHL): Timed up and go test (TUG) time emerges as a functional vital sign
    Meeting Abstract

    Torka, P.; Drill, E.; Ganesan, N.; Truong, R.; Qiu, A.; Amador, W. R.; Oliveros, M.; Boardman, A. P.; Caron, P.; David, K. A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Pembrolizumab and involved site radiation therapy alone as an alternative to transplant in patients with localized failure following chemotherapy for Hodgkin Lymphoma: A prospective multicenter phase II study
    Meeting Abstract

    Dreyfuss, A.; Ganesan, N.; Alencar, A. J.; Boardman, A. P.; Caron, P.; Chang, T.; Davey, T.; David, K. A.; Dogan, A.; Epstein-Peterson, Z. D.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Improved outcomes for primary refractory classical Hodgkin Lymphoma: A retrospective analysis
    Meeting Abstract

    Santarosa, A. M.; Ganesan, N.; Chang, T.; Hannigan, K.; Casper, E.; Shah, G. L.; Boardman, A. P.; Caron, P.; David, K. A.; Dogan, A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Real-world outcomes of frontline polatuzumab and impact of frailty in older adults with newly diagnosed diffuse large B-cell lymphoma (DLBCL)
    Meeting Abstract

    Iyengar, V.; Chicola, J.; Joseph, A.; Okwali, M.; Truong, R.; Bapodra, N.; Boardman, A. P.; Caron, P.; David, K. A.; Epstein-Peterson, Z. D.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Multicenter phase II trial of zanubrutinib, obinutuzumab, and venetoclax (BOVen) in treatment-naive chronic lymphocytic leukemia: 5-Year follow up, retreatment outcomes, and Impact of MRD kinetics (ΔMRD400)
    Meeting Abstract

    Soumerai, J. D.; Dogan, A.; Seshan, V.; Flaherty, K. L.; Slupe, N.; Carter, J.; Hochberg, E.; Barnes, J. A.; Abramson, J. S.; Hamilton, A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • High grade B-cell lymphoma with MYC/BCL6-rearrangements (R) may have inferior outcomes compared to BCL2-R disease
    Meeting Abstract

    Healton, S. E.; Luttwak, E.; Rivas-Delgado, A.; Boardman, A. P.; Caron, P.; David, K. A.; Epstein-Peterson, Z. D.; Falchi, L.; Ghione, P.; Hamlin, P. A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Prognostication and treatment-related outcomes in secondary central nervous system involvement of large B-cell lymphoma (SCNSL): Evidence from a large international cohort
    Meeting Abstract

    Alderuccio, J. P.; Khwaja, J.; Han, S.; Ghione, P.; Nizamuddin, I. A.; Saha, A.; Dong, N.; Wang, Y.; Cherng, H. J. J.; Tolu, S. S.; more...
    Blood (2024)

    Fulltext@MSK | Save